116 results on '"Thiessen, Brian"'
Search Results
2. Impact of consultation recordings on patient-reported outcomes in patients with brain tumors: a parallel randomized controlled trial
3. Patients with pretreatment leukoencephalopathy and older patients have more cognitive decline after whole brain radiotherapy
4. Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study
5. Health-related quality of life in patients with high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study
6. The DNA methylome of DDR genes and benefit from RT or TMZ in IDH mutant low-grade glioma treated in EORTC 22033
7. Treatment Patterns and Outcomes of Patients with Grade 4 Glioma Treated with Radiation during the COVID-19 Pandemic
8. NCOG-16. REAL-WORLD ANALYSIS OF OUTCOMES OF PATIENTS RECEIVING BEVACIZUMAB FOR RECURRENT GLIOBLASTOMA
9. 45: Treatment Patterns and Outcomes of Patients with High-Grade Glioma During the COVID-19 Pandemic
10. Treatment patterns and outcomes of patients with high-grade glioma during the COVID-19 pandemic.
11. Real-world analysis of outcomes of patients receiving bevacizumab for recurrent glioblastoma in British Columbia.
12. Treatment of Older Adult Patients with Glioblastoma: Moving towards the Inclusion of a Comprehensive Geriatric Assessment for Guiding Management
13. NCOG-24. REAL-WORLD ANALYSIS OF OUTCOMES OF PATIENTS RECEIVING BEVACIZUMAB FOR RECURRENT GLIOBLASTOMA IN BRITISH COLUMBIA
14. Supreme Court Clarifies Jurisdiction Of Labour Arbitrators In Human Rights Issues
15. A phase I study of temozolomide and everolimus (RAD001) in patients with newly diagnosed and progressive glioblastoma either receiving or not receiving enzyme-inducing anticonvulsants: an NCIC CTG study
16. A phase I/II trial of GW572016 (lapatinib) in recurrent glioblastoma multiforme: clinical outcomes, pharmacokinetics and molecular correlation
17. Analysis of Internet-Based Search Patterns Utilized by Glioma Patients as Information Source
18. Patients with Pretreatment Leukoencephalopathy and Older Patients have More Cognitive Decline after Whole Brain Radiotherapy
19. Loss of Heterozygosity for Loci on Chromosome Arms 1p and 10q in Oligodendroglial Tumors: Relationship to Outcome and Chemosensitivity
20. Concurrent Modified PCV Chemotherapy and Radiotherapy in Newly Diagnosed Grade IV Astrocytoma
21. Evaluation of Early Response to SU101 Target-based Therapy in Patients with Recurrent Supratentorial Malignant Gliomas Using FDG PET and Gd-DTPA MRI
22. Adjuvant Analgesics
23. Contributors
24. Astroblastoma: Does histology predict biologic behavior?
25. Clinical analysis of anti-Ma2-associated encephalitis
26. Clinical Exacerbation of Multiple Sclerosis Following Radiotherapy
27. The pivotal role of sampling recurrent tumors in the precision care of patients with tumors of the central nervous system
28. Hydrocephalus in Radiation Leukoencephalopathy: Results of Ventriculoperitoneal Shunting
29. Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial
30. Alberta Workplace Legislation Changes Effective January 1, 2018
31. An Unusual Case of Rabies Encephalitis
32. Privilege Rules: Solicitor-Client Privilege Held Sacrosanct By Alberta Court Of Appeal
33. Chapter 37 - Adjuvant Analgesics
34. Dazed And Confused: Alberta Arbitration Board Disagrees On How To Apply Top Court Ruling On Alcohol And Drug Testing
35. Phase II study of PX-866 in recurrent glioblastoma.
36. Phase II study of PX-866 in recurrent glioblastoma.
37. A phase I study of temozolomide and everolimus (RAD001) in patients with newly diagnosed and progressive glioblastoma either receiving or not receiving enzyme-inducing anticonvulsants: an NCIC CTG study
38. Phase II Trial of Continuous Dose-Intense Temozolomide in Recurrent Malignant Glioma: RESCUE Study
39. A phase I/II trial of GW572016 (lapatinib) in recurrent glioblastoma multiforme: clinical outcomes, pharmacokinetics and molecular correlation
40. Evaluation of osmolality and pH of various concentrations of methotrexate, cytarabine, and thiotepa prepared in normal saline, sterile water for injection, and lactated Ringer's solution for intrathecal administration
41. Giant cell glioblastoma: predictive and prognostic factors
42. Phase II study of PX-866 in recurrent glioblastoma.
43. Combined inhibition of the phosphatidylinositol 3-kinase/Akt and Ras/mitogen-activated protein kinase pathways results in synergistic effects in glioblastoma cells
44. SCC Rules One-Year Delay Of Privacy Inquiry Reasonable
45. Paraneoplastic Sensory Neuronopathy and Spontaneous Regression of Small Cell Lung Cancer
46. BRAIN TUMOR IMMUNOTHERAPY. 2000. Edited by Linda M. Liau, Donald P. Becker, Timothy F. Cloughesy, Darell D. Bigner. Published by Humana Press. 373pages. C$198.45 approx.
47. Drug And Alcohol Testing In The Workplace
48. Evaluation of osmolality and pH of various concentrations of methotrexate, cytarabine, and thiotepa prepared in normal saline, sterile water for injection, and lactated Ringer's solution for intrathecal administration.
49. Polyradiculopathy post-concomitant chemoradiation for carcinoma of the uterine cervix treated with pelvic and para-aortic fields
50. Giant Cell Glioblastoma: Predictive and Prognostic Factors.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.